Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.360
-0.090 (-6.21%)
At close: Dec 20, 2024, 4:00 PM
1.470
+0.110 (8.09%)
After-hours: Dec 20, 2024, 7:25 PM EST
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 41 employees as of December 31, 2023. The number of employees increased by 3 or 7.89% compared to the previous year.
Employees
41
Change (1Y)
3
Growth (1Y)
7.89%
Revenue / Employee
n/a
Profits / Employee
-$681,610
Market Cap
26.27M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41 | 3 | 7.89% |
Dec 31, 2022 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
RAPT Therapeutics | 131 |
IRIDEX | 111 |
Adagio Medical Holdings | 85 |
IGC Pharma | 67 |
KALA BIO | 43 |
BriaCell Therapeutics | 16 |
RenovoRx | 8 |
CLDI News
- 5 weeks ago - Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Announces Proposed Public Offering - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 2 months ago - Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 2 months ago - NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - GlobeNewsWire